bupropion has been researched along with Dermatitis Medicamentosa in 12 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined the efficacy of transdermal nicotine in postmenopausal smokers, and whether a history of depression or hormone replacement therapy (HRT) moderated smoking cessation outcomes." | 9.12 | Transdermal nicotine for smoking cessation in postmenopausal women. ( Cooney, J; Feinn, R; Kranzler, HR; Lando, H; Oncken, C, 2007) |
| "We report a case of erythrodermic pustular psoriasis associated with initiation of bupropion/naltrexone (Contrave®; Orexigen Therapeutics, La Jolla, CA) in a patient with no history of psoriasis." | 7.85 | Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave ( Cassel, KP; Eckersley, D; Moscati, RM; Singh, PA, 2017) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 7.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| " We report three patients with known psoriasis in whom use of bupropion (Zyban), prescribed to assist with cessation of smoking, led to severe pustular or erythrodermic exacerbation of psoriasis within 3-5 weeks." | 7.71 | Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. ( Cox, NH; Dodd, H; Gordon, PM, 2002) |
| "Bupropion is known to cause hypersensitivity reactions." | 5.40 | Pityriasis rosea-like drug eruption due to bupropion: a case report. ( Boran, Ç; Örs, I; Polat, M; Uzun, Ö, 2014) |
| "Bupropion is a very popular medication prescribed to millions of patients globally for depression (Wellbutrin, GlaxoSmithKline, Research Triangle Park, NC) as well as an aid in smoking cessation (Zyban, GlaxoSmithKline, Research Triangle Park, NC)." | 5.36 | A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. ( Chon, SY; Riddel, C; Surovik, J, 2010) |
| "This study examined the efficacy of transdermal nicotine in postmenopausal smokers, and whether a history of depression or hormone replacement therapy (HRT) moderated smoking cessation outcomes." | 5.12 | Transdermal nicotine for smoking cessation in postmenopausal women. ( Cooney, J; Feinn, R; Kranzler, HR; Lando, H; Oncken, C, 2007) |
| "We report a case of erythrodermic pustular psoriasis associated with initiation of bupropion/naltrexone (Contrave®; Orexigen Therapeutics, La Jolla, CA) in a patient with no history of psoriasis." | 3.85 | Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave ( Cassel, KP; Eckersley, D; Moscati, RM; Singh, PA, 2017) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 3.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| " We report three patients with known psoriasis in whom use of bupropion (Zyban), prescribed to assist with cessation of smoking, led to severe pustular or erythrodermic exacerbation of psoriasis within 3-5 weeks." | 3.71 | Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. ( Cox, NH; Dodd, H; Gordon, PM, 2002) |
| "Bupropion is known to cause hypersensitivity reactions." | 1.40 | Pityriasis rosea-like drug eruption due to bupropion: a case report. ( Boran, Ç; Örs, I; Polat, M; Uzun, Ö, 2014) |
| "Bupropion is a very popular medication prescribed to millions of patients globally for depression (Wellbutrin, GlaxoSmithKline, Research Triangle Park, NC) as well as an aid in smoking cessation (Zyban, GlaxoSmithKline, Research Triangle Park, NC)." | 1.36 | A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. ( Chon, SY; Riddel, C; Surovik, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Polat, M | 1 |
| Uzun, Ö | 1 |
| Örs, I | 1 |
| Boran, Ç | 1 |
| Nguyen, CV | 1 |
| Miller, DD | 1 |
| Singh, PA | 1 |
| Cassel, KP | 1 |
| Moscati, RM | 1 |
| Eckersley, D | 1 |
| Beyens, MN | 1 |
| Guy, C | 1 |
| Mounier, G | 1 |
| Laporte, S | 1 |
| Ollagnier, M | 1 |
| Surovik, J | 1 |
| Riddel, C | 1 |
| Chon, SY | 1 |
| Fays, S | 1 |
| Tréchot, P | 1 |
| Schmutz, JL | 1 |
| Cuny, JF | 1 |
| Truchetet, F | 1 |
| Barbaud, A | 1 |
| Loo, WJ | 1 |
| Alexandroff, A | 1 |
| Flanagan, N | 1 |
| Petersen, P | 1 |
| Oncken, C | 1 |
| Cooney, J | 1 |
| Feinn, R | 1 |
| Lando, H | 1 |
| Kranzler, HR | 1 |
| McLean, SE | 1 |
| Pirie, SD | 1 |
| Benson, E | 1 |
| Cox, NH | 1 |
| Gordon, PM | 1 |
| Dodd, H | 1 |
1 trial available for bupropion and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Transdermal nicotine for smoking cessation in postmenopausal women.
Topics: Administration, Cutaneous; Bupropion; Chest Pain; Counseling; Double-Blind Method; Drug Eruptions; F | 2007 |
11 other studies available for bupropion and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Pityriasis rosea-like drug eruption due to bupropion: a case report.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Drug Eruptions; Fem | 2014 |
Serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern.
Topics: Aged; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Bupropion; Cefazolin; Drug Er | 2017 |
Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave
Topics: Acute Kidney Injury; Biopsy; Bupropion; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; | 2017 |
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
Topics: Adolescent; Adult; Aged; Angioedema; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovas | 2008 |
A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Drug Erupti | 2010 |
Bupropion and generalized acute urticaria: eight cases.
Topics: Acute Disease; Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Drug Eruption | 2003 |
Bupropion and generalized acute urticaria: a further case.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitor | 2003 |
[Reporting of adverse effects].
Topics: Adverse Drug Reaction Reporting Systems; Bupropion; Drug Eruptions; Drug Industry; Humans; Joint Dis | 2004 |
A 30-year-old woman with a generalized rash.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Drug Eruptions; Emergency Nursing; Emerg | 1999 |
Bupropion-induced hypersensitivity reactions.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Biopsy; Bupropion; Dopamin | 2001 |
Generalized pustular and erythrodermic psoriasis associated with bupropion treatment.
Topics: Adult; Bupropion; Dermatitis, Exfoliative; Dopamine Uptake Inhibitors; Drug Eruptions; Female; Human | 2002 |